PCSK9 Inhibitor Research Paper

PCSK9 Inhibitor Research Paper

USPSTF

Standing in the Way of Pediatric Screening

No Comments

The Family Heart Foundation’s Back and Forth with the United States Preventive Services Task Force

Since 2011 the American Academy of Pediatrics (AAP) and the National Institutes of Health (NIH) have recommended screening children at the age of 2 if they have a family history of premature vascular … Read More →


Research

2023 Family Heart Foundation Research Highlights

No Comments

When it comes to the diagnosis and treatment of familial hypercholesterolemia (FH) and elevated lipoprotein(a), or Lp(a), there are still so many unanswered questions.
What we have learned from our research is impacting peoples’ lives right now. We are using artificial intelligence to address the … Read More →


Shining a Light on LDL Cholesterol Management in America

No Comments

September is National Cholesterol Education Month, and that makes it the perfect time to shine a light on cholesterol management in America. Family Heart Foundation research shows that 70% of Americans at high-risk for cardiovascular disease never get their LDL (“bad”) cholesterol to recommended … Read More →


The US is Frequently Missing the HoFH Diagnosis

HoFH in the U.S.

Lipoprotein(a) Awareness Day Recap

2023 Lipoprotein(a) Awareness Day Tweet-a-thon

A Roundup of the Best Tweets from the 2nd Annual Lp(a) Awareness Day Tweet-a-Thon

No Comments

On March 24, the Family Heart Foundation held their second annual Lp(a) Awareness Day Tweet-a-Thon. It’s an incredibly impactful way to spread awareness and educate others on high lipoprotein(a), also known as Lp(a). This year we reached over 12 million people with our hashtag #KnowLpa!
ICYMI, here … Read More →


Some High-Risk American Have Higher Rate of Cardiovascular Events

High-Risk American Not Reaching LDL-C Target Have Higher Rate of Cardiovascular Events

No Comments

Family Heart Foundation Research Finds High-Risk Americans Who Do Not Maintain Guideline Recommended LDL-C Targets Have 44% Higher Rate of Cardiovascular Events

Findings Based on Real-World Analysis to be Presented at AMCP 2023

SAN ANTONIO, March 21, 2023 – A real-world, retrospective analysis … Read More →